Home › Funds › DYMON ASIA CAPITAL (SINGAPORE) PTE. LTD. › JNJ

DYMON ASIA CAPITAL (SINGAPORE) PTE. LTD. position in JNJ

JOHNSON & JOHNSON · Health Care

DYMON ASIA CAPITAL (SINGAPORE) PTE. LTD. reported holding 18,300 shares of JNJ (JOHNSON & JOHNSON) in its Q2 2026 13F filing — a position valued at US$4.6M, representing 0.52% of its reported portfolio and ranking #46 among its reported holdings. DYMON ASIA CAPITAL (SINGAPORE) PTE. LTD. has disclosed JNJ holdings in 5 of the last 5 reported quarters, going back to Q2 2025.

Latest position (Q2 2026)18.30K sh
Reported value held$4.65M
Portfolio Weight0.52%
First reportedQ2 2025
Last changeAdd
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How DYMON ASIA CAPITAL (SINGAPORE) PTE. LTD.'s JNJ position evolved

DYMON ASIA CAPITAL (SINGAPORE) PTE. LTD. first disclosed a stake in JNJ in Q2 2025 at 14,000 shares (US$2.1M). The position peaked in Q2 2026 at 18,300 shares, worth US$4.6M. Across 5 filings, DYMON ASIA CAPITAL (SINGAPORE) PTE. LTD. increased the stake 2 time(s), trimmed it 2 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 18,300 shares valued at US$4.6M — an increase of 3,900 shares quarter over quarter.. Notable position changes include a 59% trim in Q4 2025 (shares rose 18% over the following quarter), a 191% increase in Q1 2026 (shares rose 4% over the following quarter), a 27% increase in Q2 2026 (shares rose 4% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q2 2025 14.00K $2.14M New
Q3 2025 12.00K $2.23M Reduce
Q4 2025 4.95K $1.02M Reduce
Q1 2026 14.40K $3.52M Add
Q2 2026 18.30K $4.65M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About JNJ and 13F data

JNJ (JOHNSON & JOHNSON) is a Health Care company. 33 other funds we track also report a position in JNJ — the largest reported positions include BlackRock Inc (US$53.87B), Vanguard Group (US$49.74B), VANGUARD CAPITAL MANAGEMENT LLC (US$39.93B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding JNJ

All JNJ fund holders →

FAQ

How long has DYMON ASIA CAPITAL (SINGAPORE) PTE. LTD. held JNJ?

DYMON ASIA CAPITAL (SINGAPORE) PTE. LTD. has disclosed JNJ holdings in 5 of the last 5 reported quarters, going back to Q2 2025.

What is DYMON ASIA CAPITAL (SINGAPORE) PTE. LTD.'s current position in JNJ?

As of Q2 2026, DYMON ASIA CAPITAL (SINGAPORE) PTE. LTD. holds 18.30K shares of JNJ (JOHNSON & JOHNSON), valued at $4.65M, representing 0.52% of its reported portfolio and ranking #46.

Has DYMON ASIA CAPITAL (SINGAPORE) PTE. LTD. been buying or selling JNJ?

In the latest 13F filing (Q2 2026), DYMON ASIA CAPITAL (SINGAPORE) PTE. LTD. increased its position in JNJ. The position peaked in Q2 2026 at 18.30K shares.

Which other funds hold JNJ?

Other major institutional holders of JNJ include BlackRock Inc, Vanguard Group, VANGUARD CAPITAL MANAGEMENT LLC, among 33 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.